The serum thioredoxin-1 levels are not associated with bronchopulmonary dysplasia and retinopathy of prematurity

CONCLUSION: The serum TRX-1 levels after birth are not predictive of severe BPD and ROP.IMPACT: Serum thioredoxin-1 levels in extremely preterm infants on the day of birth are lower than those in term or near-term infants hospitalized for transient tachypnea of the newborn. In extremely preterm infants, the serum thioredoxin-1 levels on the day of birth, at 10-20 days of life, and at postmenstrual age of 36-40 weeks were not associated with severe bronchopulmonary dysplasia and retinopathy of prematurity. The thioredoxin system is under development in extremely preterm infants; however, the serum thioredoxin-1 level is not predictive for severe bronchopulmonary dysplasia and retinopathy of prematurity.PMID:38365875 | DOI:10.1038/s41390-024-03078-7
Source: Pediatric Research - Category: Pediatrics Authors: Source Type: research